Yüklüyor......
Off-Label Use of Recombinant Factor VIIa in United States Hospitals: 2000–2008
BACKGROUND: Recombinant factor VIIa (rFVIIa) is approved for treatment of bleeding in hemophilia patients with inhibitors but has been applied to a wide range of off-label indications. OBJECTIVE: To estimate patterns of off-label rFVIIa use in United States hospitals. DESIGN: Retrospective database...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4011398/ https://ncbi.nlm.nih.gov/pubmed/21502649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/0003-4819-154-8-201104190-00002 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|